Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.18USD
10:46am EDT
Change (% chg)

$0.06 (+1.92%)
Prev Close
$3.12
Open
$3.12
Day's High
$3.18
Day's Low
$3.12
Volume
2,613
Avg. Vol
34,203
52-wk High
$4.67
52-wk Low
$3.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
FY 2016 Dec '16 0.04 -0.059
Sep '16 0.05 -0.067
Jun '16 0.15 -0.084
Mar '16 0.04 -0.076
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.89 34.04
P/E High - Last 5 Yrs. -- 290.95 47.73
P/E Low - Last 5 Yrs. -- 100.14 25.07
Beta 0.64 0.73 0.78
Price to Sales (TTM) 642.24 249.29 8.22
Price to Book (MRQ) -- 23.95 4.29
Price to Tangible Book (MRQ) -- 30.87 6.00
Price to Cash Flow (TTM) -- 143.83 22.60
% Owned Institutions 6.19 11.87 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.18 -6.32
Payout Ratio(TTM) -- 42.00 40.51

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 93.90 25.06 5.40
Sales (TTM) vs TTM 1 Yr. Ago -7.14 135.46 12.76
Sales - 5 Yr. Growth Rate -40.77 31.25 7.90
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.52 -86.73 41.23
EPS (TTM) vs TTM 1 Yr. Ago 7.88 -- --
EPS - 5 Yr. Growth Rate -- 49.02 8.05
Capital Spending - 5 Yr. Growth Rate -- 36.46 7.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.46 1.68 2.55
Current Ratio (MRQ) 0.47 6.34 3.62
LT Debt to Equity (MRQ) -- 22.40 13.12
Total Debt to Equity (MRQ) -- 26.77 17.61
Interest Coverage (TTM) -52.99 -137.51 36.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 45.29 56.81 55.04
Gross Margin - 5 Yr. Avg. 88.07 55.33 52.94
EBITD Margin (TTM) -4,411.78 -- --
EBITD - 5 Yr. Avg -557.02 -163.88 15.76
Operating Margin (TTM) -4,412.07 -890.63 -0.32
Operating Margin - 5 Yr. Avg. -557.29 -177.36 10.97
Pre-Tax Margin (TTM) -4,461.98 -785.00 1.62
Pre-Tax Margin - 5 Yr. Avg. -563.69 -180.78 11.14
Net Profit Margin (TTM) -4,461.98 -778.64 -1.66
Net Profit Margin - 5 Yr. Avg. -563.15 -179.59 7.49
Effective Tax Rate (TTM) -- 15.47 29.83
Effective Tax Rate - 5 Yr. Avg. -- 19.38 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 148,805 21,870,457 728,113,809
Net Income/Employee (TTM) -6,639,645 -128,268 84,561,813
Receivable Turnover (TTM) 20.01 18.25 6.05
Inventory Turnover (TTM) 21.35 2.86 3.66
Asset Turnover (TTM) 0.22 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -998.03 -3.57 10.33
Return on Assets - 5 Yr. Avg. -826.65 -0.69 11.01
Return on Investment (TTM) -- -5.30 13.11
Return on Investment - 5 Yr. Avg. -- 2.14 14.30
Return on Equity (TTM) -- -6.83 15.11
Return on Equity - 5 Yr. Avg. -- -2.87 15.65
  1 Year 3 Year 5 Year
Sales % -21.02 -57.65 -40.77
EPS (TTM) % 10.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.19%
# of Holders: 76
Total Shares Held: 3,531,751
3 Mo. Net Change: -66,018
# New Positions: 14
# Closed Positions: 5
# Increased Positions: 32
# Reduced Positions: 20
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.